Advertisement

Obesity Surgery

, Volume 18, Issue 2, pp 167–170 | Cite as

Hemorrhagic and Thromboembolic Complications after Bariatric Surgery in Patients Receiving Chronic Anticoagulation Therapy

  • Ramon Mourelo
  • Orit Kaidar-Person
  • Patricio Fajnwaks
  • Paul E. Roa
  • David Pinto
  • Samuel Szomstein
  • Raul J. Rosenthal
Research Article

Abstract

Background

Perioperative management of bariatric surgical patients receiving chronic anticoagulation requires an understanding of potential hemorrhagic and thromboembolic risks. The aim of this study is to evaluate hemorrhagic and thromboembolic complications in morbidly obese patients who are on oral anticoagulation treatment and subsequently undergo laparoscopic bariatric surgery.

Methods

The medical records of all laparoscopic Roux-en-Y gastric bypass (LRYGB) patients from June 2001 to March 2006 were retrospectively reviewed. In addition, data of patients who received chronic anticoagulation therapy with Coumadin and underwent laparoscopic Roux-en-Y gastric bypass was analyzed. Clinical parameters included length of hospitalization, hemorrhagic complications, thromboembolic complications, conversion rate, reoperation, and blood transfusion.

Results

During the study period, 1,700 consecutive patients underwent bariatric surgery for the treatment of morbid obesity. Of these, 21 patients were treated with chronic oral anticoagulation; 3 of the 21 (14%) had hemorrhagic complications: one patient had intraluminal hemorrhage and two patients had intraabdominal hemorrhage. Two patients required blood transfusion, and one patient underwent surgical reintervention. None of the 21 laparoscopic operations were converted to open procedures. There were no postoperative mortalities, and there were no thromboembolic events in this series.

Conclusions

Laparoscopic bariatric surgery can be performed relatively safely in morbidly obese patients who are treated with chronic oral anticoagulation. Even in the presence of bleeding, patients can be successfully treated without the need for reoperation.

Keywords

Laparoscopy Bariatric surgery Coumadin Anticoagulation Obesity Complications 

References

  1. 1.
    Drug Topics (2006) http://www.drugtopics.com/drugtopics/. Cited 13 August 2006.
  2. 2.
    Poirier P, Giles TD, Bray GA, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss. Arterioscler Thromb Vasc Biol 2006;26(5):968–76.PubMedCrossRefGoogle Scholar
  3. 3.
    Abramson N, Abramson S. Hypercoagulability: clinical assessment and treatment. South Med J 2001;94(10):1013–20.PubMedGoogle Scholar
  4. 4.
    Heit JD. Perioperative management of the chronically anticoagulated patient. J Thromb Thrombolysis 2001;12(1):81–7.PubMedCrossRefGoogle Scholar
  5. 5.
    Hayashi H, Ochiai T, Shimada H, Gunji Y. Prospective randomized study of open versus laparoscopy-assisted distal gastrectomy with extraperigastric lymph node dissection for early gastric cancer. Surg Endosc 2005;19(9):1172–6.PubMedCrossRefGoogle Scholar
  6. 6.
    Lee JH, Han HS, Lee JH. A prospective randomized study comparing open vs laparoscopy-assisted distal gastrectomy in early gastric cancer: early results. Surg Endosc 2005;19(2):168–73.PubMedCrossRefGoogle Scholar
  7. 7.
    Katholi RE, Nolan SP, McGuire LB. The management of anticoagulation during noncardiac operations in patients with prosthetic heart valves. A prospective study. Am Heart J 1978;96(2):163–5.PubMedCrossRefGoogle Scholar
  8. 8.
    Varkarakis IM, Rais-Bahrami S, Allaf ME, et al. Laparoscopic renal–adrenal surgery in patients on oral anticoagulant therapy. J Urol 2005;174(3):1020–3.PubMedCrossRefGoogle Scholar
  9. 9.
    Yoshida T, Kitano T, Matsumoto T, et al. Laparoscopic cholecystectomy in patients undergoing anticoagulant therapy. Surg Today 1998;28(3):308–12.PubMedCrossRefGoogle Scholar
  10. 10.
    Mehran A, Szomstein S, Zundel N, Rosenthal R. Management of acute bleeding after laparoscopic gastric bypass. Obes Surg 2003;13(6):842–7.PubMedCrossRefGoogle Scholar
  11. 11.
    Syed M, Jafri M. Periprocedural management of anticoagulation in patients on extended warfarin therapy. Semin Thromb Hemost 2004;30(6):657–64.CrossRefGoogle Scholar
  12. 12.
    Travis S, Wray R, Harrison K. Perioperative anticoagulant control. Br J Surg 1989;76:1107–8.PubMedCrossRefGoogle Scholar
  13. 13.
    Palareti G, Legnani C. Warfarin withdrawal. Pharmacokinetic–pharmacodynamic considerations. Clin Pharmacokinet 1996;30(4):300–13.PubMedCrossRefGoogle Scholar
  14. 14.
    White RH, McKitrick T, Hutchinson R, et al. Temporary discontinuation of warfarin therapy: changes in the international normalized ratio. Ann Intern Med 1995;122(1):40–2.PubMedGoogle Scholar
  15. 15.
    Despotits GJ, Filos KS, Zoys TN, et al. Factors associated with excessive postoperative blood loss and hemostatic transfusion requirements: a multivariate analysis in cardiac surgical patients. Anesth Analg 1996;82:13–21.CrossRefGoogle Scholar
  16. 16.
    Crowther MA, Julian J, McCarthy D, et al. Low dose oral vitamin K for the treatment of warfarin associated coagulopathy. Lancet 2000;356:1551–3.PubMedCrossRefGoogle Scholar
  17. 17.
    Kearon C, Hirsh J. Managing oral anticoagulation before and after elective surgery. N Engl J Med 1997;336:1506–11.PubMedCrossRefGoogle Scholar
  18. 18.
    Hewitt RL, Chun KL, Flint LM. Current clinical concepts in perioperative anticoagulation. Am Surg 1999;65:270–3.PubMedGoogle Scholar

Copyright information

© Springer Science + Business Media B.V. 2007

Authors and Affiliations

  • Ramon Mourelo
    • 1
  • Orit Kaidar-Person
    • 1
  • Patricio Fajnwaks
    • 1
  • Paul E. Roa
    • 1
  • David Pinto
    • 1
  • Samuel Szomstein
    • 1
  • Raul J. Rosenthal
    • 1
  1. 1.Department of Surgery, The Bariatric and Metabolic Institute and Section of Minimally Invasive SurgeryCleveland Clinic FloridaWestonUSA

Personalised recommendations